Nebulizer Choice Affects the Airway Targeting of Amphotericin B Lipid Complex Aerosols - Maria Polikandritou Lambros, Paul M. Beringer, Annie Wong-Beringer, 2013
Pharmaceutics | Free Full-Text | Could the Lung Be a Gateway for Amphotericin B to Attack the Army of Fungi?
Aerosolized liposomal amphotericin B: Prediction of lung deposition, in vitro uptake and cytotoxicity - ScienceDirect
Targeting lung macrophages for fungal and parasitic pulmonary infections with innovative amphotericin B dry powder inhalers - ScienceDirect
Ambisome – Firma Buurman
Ablc e trapianto di polmone | PPT
Distribution of amphotericin B as a function of time in plasma... | Download Scientific Diagram
PDF) Aerosolized liposomal Amphotericin B: A potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients | H. Kamalaporn and Saranya Kittanakom - Academia.edu
Aerosolized liposomal Amphotericin B: A potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients - Kamalaporn - 2014 - Pediatric Pulmonology - Wiley Online Library
Figure 2 from Bioactivity, Safety, and Efficacy of Amphotericin B Nanomicellar Aerosols Using Sodium Deoxycholate Sulfate as the Lipid Carrier | Semantic Scholar
Abelcet | C47H73NO17 | CID 14956 - PubChem
Nebulizer Choice Affects the Airway Targeting of Amphotericin B Lipid Complex Aerosols - Maria Polikandritou Lambros, Paul M. Beringer, Annie Wong-Beringer, 2013
The efficacy of aerosol treatment with non-ionic surfactant vesicles containing amphotericin B in rodent models of leishmaniasis and pulmonary aspergillosis infection - ScienceDirect
Ambisome <br> Antifungal Amphotericin B Liposome <br>50 mg / 20 mL Intravenous Injection <br>Vial 20 mL <br> Astellas 00469305130
Notice patient - AMBISOME liposomal 50 mg, poudre pour dispersion pour perfusion - Base de données publique des médicaments
PDF] Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis. | Semantic Scholar
Aerosolization of Liposomal Amphotericin B (AmBisome®) Maintains Antifungal Drug Concentrations in Lungs for up to Five Days Po
The release of AmBisome® (a) and free Amp B (b) from Float-A-Lyzer®... | Download Scientific Diagram
Notice patient - AMBISOME liposomal 50 mg, poudre pour dispersion pour perfusion - Base de données publique des médicaments
Pharmaceutics | Free Full-Text | A Critical Review on Emerging Trends in Dry Powder Inhaler Formulation for the Treatment of Pulmonary Aspergillosis
Pharmaceutics | Free Full-Text | Could the Lung Be a Gateway for Amphotericin B to Attack the Army of Fungi?
Preclinical Studies of the Nebulized Delivery of Liposomal Amphotericin B | Journal of Aerosol Medicine and Pulmonary Drug Delivery
Aerosol Deposition of Lipid Complex Amphotericin-B (Abelcet) in Lung Transplant Recipients - ScienceDirect
Aerosolization of Liposomal Amphotericin B (AmBisome®) Maintains Antifungal Drug Concentrations in Lungs for up to Five Days Po
Chronic Pulmonary Aspergillosis and Ambisome Aerosol With Itraconazole | Clinical Research Trial Listing ( Chronic Pulmonary Aspergillosis ) ( NCT03656081 )